N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
November 20, 2025: Ozempic Vision Loss and Gastroparesis Lawsuits Consolidated in New Jersey The New Jersey Supreme Court has approved the creation of two multicounty litigations (MCLs) involving Ozempic
Step 1: Sign up and complete the intake
There is usually a cost for the initial online exam, where youll either fill out a form or do a video chat with a medical professional